Axon Enterprise (NASDAQ:AXON) Price Target Raised to $142.00 at Credit Suisse Group
Axon Enterprise (NASDAQ:AXON) Price Target Raised to $142.00 at Credit Suisse Group
Axon Enterprise (NASDAQ:AXON – Get Rating) had its price target increased by Credit Suisse Group from $134.00 to $142.00 in a research note released on Wednesday morning, The Fly reports. The firm currently has an outperform rating on the biotechnology company's stock.
据The Fly报道，在周三上午发布的一份研究报告中，瑞士信贷集团将Axon Enterprise(纳斯达克：AXON-GET评级)的目标价从134.00美元上调至142.00美元。该公司目前对这家生物技术公司的股票有跑赢大盘的评级。
A number of other research firms have also weighed in on AXON. JMP Securities restated a buy rating and set a $195.00 target price on shares of Axon Enterprise in a research note on Wednesday, June 1st. Northland Securities dropped their price target on shares of Axon Enterprise from $180.00 to $130.00 in a research note on Thursday, May 12th. StockNews.com upgraded shares of Axon Enterprise from a hold rating to a buy rating in a research note on Saturday, June 18th. Robert W. Baird dropped their price target on shares of Axon Enterprise from $145.00 to $125.00 in a research note on Wednesday, May 11th. Finally, Morgan Stanley lowered shares of Axon Enterprise from an overweight rating to an equal weight rating and set a $120.00 price target on the stock. in a research note on Monday, May 23rd. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus price target of $163.25.
其他一些研究公司也参与了Axon的研究。JMP证券在6月1日星期三的一份研究报告中重申了买入评级，并为Axon Enterprise的股票设定了195.00美元的目标价。Northland Securities在5月12日星期四的一份研究报告中将Axon Enterprise的目标股价从180.00美元下调至130.00美元。在6月18日星期六的一份研究报告中，StockNews.com将Axon Enterprise的股票评级从持有评级上调为买入评级。罗伯特·W·贝尔德在5月11日星期三的一份研究报告中将Axon Enterprise的目标股价从145.00美元下调至125.00美元。最后，摩根士丹利将Axon Enterprise的股票评级从增持下调至持平评级，并为该股设定了120.00美元的目标价。在5月23日星期一的一份研究报告中。一名投资分析师对该股的评级为持有，八名分析师对该公司的评级为买入。根据MarketBeat的数据，该股目前的平均评级为适度买入，共识目标价为163.25美元。
Axon Enterprise Trading Down 0.3 %
Axon企业股价下跌0.3%
NASDAQ:AXON traded down $0.36 on Wednesday, reaching $125.71. 3,253 shares of the company's stock were exchanged, compared to its average volume of 272,527. The company has a quick ratio of 2.18, a current ratio of 2.43 and a debt-to-equity ratio of 0.02. The firm has a market capitalization of $8.93 billion, a price-to-earnings ratio of 64.65 and a beta of 0.66. The business has a fifty day moving average of $97.61 and a 200-day moving average of $112.50. Axon Enterprise has a 52-week low of $82.49 and a 52-week high of $209.00.
纳斯达克：Axon周三下跌0.36美元，至125.71美元。该公司股票成交量为3253股，而其平均成交量为272527股。该公司的速动比率为2.18，流动比率为2.43，债务权益比为0.02。该公司的市值为89.3亿美元，市盈率为64.65倍，贝塔系数为0.66。该业务的50日移动均线切入位在97.61美元，200日移动均线切入位在112.50美元。Axon Enterprise的52周低点为82.49美元，52周高位为209.00美元。
Insider Buying and Selling at Axon Enterprise
Axon Enterprise的内幕买卖
In other news, Director Mark W. Kroll sold 3,159 shares of the firm's stock in a transaction on Wednesday, June 8th. The stock was sold at an average price of $102.82, for a total value of $324,808.38. Following the completion of the transaction, the director now owns 13,691 shares in the company, valued at $1,407,708.62. The sale was disclosed in a document filed with the SEC, which is available at this link. 6.90% of the stock is owned by corporate insiders.
在其他新闻方面，董事马克·克罗尔在6月8日星期三的一次交易中出售了3159股该公司股票。这只股票的平均售价为102.82美元，总价值为324,808.38美元。交易完成后，董事现在拥有该公司13,691股，价值1,407,708.62美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，可以通过以下链接获得。6.90%的股份由企业内部人士持有。
Institutional Inflows and Outflows
机构资金流入和流出
A number of hedge funds have recently made changes to their positions in AXON. Capital International Investors increased its position in Axon Enterprise by 605.2% during the 1st quarter. Capital International Investors now owns 2,660,634 shares of the biotechnology company's stock worth $366,449,000 after purchasing an additional 2,283,343 shares in the last quarter. BlackRock Inc. increased its position in Axon Enterprise by 6.2% during the 4th quarter. BlackRock Inc. now owns 7,366,629 shares of the biotechnology company's stock worth $1,156,559,000 after purchasing an additional 426,830 shares in the last quarter. William Blair Investment Management LLC increased its position in Axon Enterprise by 22.2% during the 2nd quarter. William Blair Investment Management LLC now owns 2,130,903 shares of the biotechnology company's stock worth $198,536,000 after purchasing an additional 386,861 shares in the last quarter. State Street Corp increased its position in Axon Enterprise by 13.3% during the 1st quarter. State Street Corp now owns 2,220,692 shares of the biotechnology company's stock worth $305,856,000 after purchasing an additional 261,508 shares in the last quarter. Finally, Capital Group International Inc. CA boosted its stake in Axon Enterprise by 263.6% in the 1st quarter. Capital Group International Inc. CA now owns 286,404 shares of the biotechnology company's stock worth $39,446,000 after buying an additional 207,638 shares during the last quarter. Hedge funds and other institutional investors own 72.06% of the company's stock.
一些对冲基金最近改变了他们在Axon的头寸。第一季度，Capital International Investors将其在Axon Enterprise的持仓增加了605.2%。Capital International Investors现在持有这家生物技术公司2,660,634股股票，价值366,449,000美元，上个季度又购买了2,283,343股。贝莱德股份有限公司在第四季度增持了安盛企业的股份6.2%。贝莱德股份有限公司现在持有这家生物技术公司的7,366,629股股票，价值1,156,559,000美元，该公司在上个季度又购买了426,830股。威廉·布莱尔投资管理公司在第二季度将其在Axon Enterprise的头寸增加了22.2%。威廉·布莱尔投资管理公司现在持有这家生物技术公司2130,903股股票，价值198,536,000美元，上个季度又购买了386,861股。道富集团在第一季度将其在Axon Enterprise的头寸增加了13.3%。道富集团目前持有这家生物技术公司2,220,692股股票，价值305,856,000美元，此前该公司在上个季度又购买了261,508股。最后，资本集团国际公司在第一季度将其在Axon Enterprise的持股增加了263.6%。Capital Group International Inc.目前持有286,404股这家生物技术公司的股票，价值39,446,000美元，上个季度又购买了207,638股。对冲基金和其他机构投资者持有该公司72.06%的股份。
About Axon Enterprise
关于Axon Enterprise
(Get Rating)
(获取评级)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Axon Enterprise，Inc.在美国和国际上以泰瑟品牌开发、制造和销售导电能源设备(CED)。它通过两个部分运作，泰瑟枪和软件和传感器。该公司还提供硬件和基于云的软件解决方案，使执法部门能够捕获、安全存储、管理、共享和分析视频和其他数字证据。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
- Find and Profitably Trade Stocks at 52-Week Lows
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
- Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
- 免费获取StockNews.com关于Axon Enterprise(Axon)的研究报告
- 找到并获利于52周低点的股票交易
- 迪士尼(NYSE：DIS)的股票刚刚给了投资者一个巨大的信号
- 清洁能源法案通过后，太阳能股大放异彩
- 颠簸时代的3只稳定成长股
- 大型和小型石油和天然气类股盈利后反弹
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
接受Axon企业日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收Axon Enterprise和相关公司的最新新闻和分析师评级的每日简明摘要。